8-K/A 1 j1286_8ka.htm 8-K/A

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

Amendment No. 1 on

 

FORM 8-K/A

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d)

 

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported):  May 13, 2003

 

INTERLEUKIN GENETICS, INC.

(Exact name of registrant as specified in its charter)

 

DELAWARE

 

000-23413

 

94-3123681

(State or other
jurisdiction of
incorporation)

 

(Commission
File Number)
94-3123681

 

(IRS Employer
Identification No.)

 

 

 

 

 

135 BEAVER STREET, WALTHAM, MA  02452

(Address of principal executive offices) (Zip Code)

 

 

 

 

 

Registrant’s telephone number, including area code: (781) 398-0700

 

 

 

 

 

Not Applicable

(Former name or former address, if changed since last report)

 

 



 

The purpose of this amendment to our Current Report on Form 8-K filed with the Securities Exchange Commission on May 13, 2003, is to change the Item under which the press release reporting our results for the quarter ended March 31, 2003 appears.

 

ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS.

 

(c)

Exhibit

 

99.1

Press Release dated May 13, 2003

 

ITEM 9.  REGULATION FD DISCLOSURE (INFORMATION FILED PURSUANT TO ITEM 12, “RESULTS OF OPERATIONS AND FINANCIAL CONDITION”).

 

On May 13, 2003, Interleukin Genetics, Inc. publicly disseminated a press release reporting its results for the quarter ended March 31, 2003.  The information contained in the press release is incorporated herein by reference and filed as Exhibit 99.1 hereto.

 

This information filed under “Item 9. Regulation FD Disclosure” is intended to be filed under “Item 12. Results of Operations and Financial Condition” in accordance with SEC Release No. 33-8216.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

INTERLEUKIN GENETICS, INC.

 

 

 

 

(Registrant)

 

Date:

May 19, 2003

 

/s/ Fenel M. Eloi

 

 

 

 

 

 

Fenel M. Eloi, Chief Operating Officer,
Chief Financial Officer, Treasurer and
Secretary and Treasurer

 

3



 

EXHIBIT INDEX

 

Exhibit
Number

 

Description

 

 

 

99.1

 

Press Release dated May 13, 2003

 

4